ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for acetaminophen; caffeine; dihydrocodeine bitartrate and what is the scope of patent protection?
Acetaminophen; caffeine; dihydrocodeine bitartrate
is the generic ingredient in five branded drugs marketed by Mikart, Wraser Pharms Llc, Pharm Res Assoc, Leitner Pharms, Key Therap, Larken Labs Inc, Boca Pharma Llc, and West-ward Pharm Corp, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.One supplier is listed for this compound.
Summary for ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
| US Patents: | 0 |
| Tradenames: | 5 |
| Applicants: | 8 |
| NDAs: | 9 |
| Finished Product Suppliers / Packagers: | 1 |
| DailyMed Link: | ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE at DailyMed |
Pharmacology for ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
| Drug Class | Central Nervous System Stimulant Methylxanthine Opioid Agonist |
| Mechanism of Action | Full Opioid Agonists |
| Physiological Effect | Central Nervous System Stimulation |
Anatomical Therapeutic Chemical (ATC) Classes for ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
US Patents and Regulatory Information for ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| West-ward Pharm Corp | ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE | acetaminophen; caffeine; dihydrocodeine bitartrate | TABLET;ORAL | 040637-001 | Sep 22, 2006 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Larken Labs Inc | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | acetaminophen; caffeine; dihydrocodeine bitartrate | TABLET;ORAL | 204209-001 | Sep 30, 2016 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mikart | ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE | acetaminophen; caffeine; dihydrocodeine bitartrate | TABLET;ORAL | 040316-001 | Apr 28, 1999 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wraser Pharms Llc | ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE | acetaminophen; caffeine; dihydrocodeine bitartrate | CAPSULE;ORAL | 040688-001 | Apr 3, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharm Res Assoc | DHC PLUS | acetaminophen; caffeine; dihydrocodeine bitartrate | CAPSULE;ORAL | 088584-001 | Mar 4, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Leitner Pharms | SYNALGOS-DC-A | acetaminophen; caffeine; dihydrocodeine bitartrate | CAPSULE;ORAL | 089166-001 | May 14, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mikart | ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE | acetaminophen; caffeine; dihydrocodeine bitartrate | CAPSULE;ORAL | 040109-001 | Aug 26, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
